Key F Inancial Inc Harrow Health, Inc. Transaction History
Key F Inancial Inc
- $433 Million
- Q4 2024
A detailed history of Key F Inancial Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Key F Inancial Inc holds 750 shares of HROW stock, worth $24,127. This represents 0.01% of its overall portfolio holdings.
Number of Shares
750
Previous 750
-0.0%
Holding current value
$24,127
Previous $33,000
24.24%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.2MCall Options Held
844KPut Options Held
698K-
Opaleye Management Inc. Boston, MA3.99MShares$128 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$69.6 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$69.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$60.1 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$23.5 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $871M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...